FTC Holds Roundtable On Follow-On Biologics
1 CommentBy Ed Silverman // November 21st, 2008 // 7:22 am
• Pharma Blog » Archives
Follow On Biologics
Specialty Med Prices Greatly Outstrip Inflation
1 CommentBy Ed Silverman // September 25th, 2008 // 1:07 pm
FTC Reviewing Follow-On Biologics And Competition
Make a commentBy Ed Silverman // August 28th, 2008 // 4:38 pm
Insmed Develops Biologic For Amgen’s Neupogen
2 CommentsBy Ed Silverman // July 10th, 2008 // 9:02 am
The Biosimilar Pathway Is Filled With Obstacles
Make a commentBy Ed Silverman // June 17th, 2008 // 2:28 pm
How Do You Spell Biogenerics? G-R-I-D-L-O-C-K
Make a commentBy Ed Silverman // February 14th, 2008 // 5:01 pm
Meet Mike, Your Generic Biologics Lobbyist
2 CommentsBy Ed Silverman // February 11th, 2008 // 8:43 am
BIO’s Greenwood On Patents And Biologics
Make a commentBy Ed Silverman // September 19th, 2007 // 7:14 am